XML 108 R84.htm IDEA: XBRL DOCUMENT v3.25.2
Net Loss Per Share (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of shares converted in to notes 1,739,130  
Number of shares converted in to option   3,702,360
Warrants exercisable price per share (in Dollars per share)   $ 15
Warrants outstanding   925,590
Series A [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of warrants related to legacy 869,565  
Warrants exercisable price per share (in Dollars per share) $ 12.5  
Series C [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of warrants related to legacy 869,565  
Warrants exercisable price per share (in Dollars per share) $ 11.5  
FTAC Emerald [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of warrants related to legacy   12,434,658
Warrants exercisable price per share (in Dollars per share)   $ 11.5